Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00YPO
|
||||
| Former ID |
DNC004302
|
||||
| Drug Name |
TETRAHYDROBENXIMIDAZOLE
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [533015] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C18H20N4O
|
||||
| Canonical SMILES |
CC1CC(=O)NN=C1C2=CC=C(C=C2)N3C=NC4=C3CCCC4
|
||||
| InChI |
1S/C18H20N4O/c1-12-10-17(23)20-21-18(12)13-6-8-14(9-7-13)22-11-19-15-4-2-3-5-16(15)22/h6-9,11-12H,2-5,10H2,1H3,(H,20,23)
|
||||
| InChIKey |
KDEKNYKHIZTSLE-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | CGMP-inhibited 3',5'-cyclic phosphodiesterase A | Target Info | Inhibitor | [533015] | |
| References | |||||
| Ref 533015 | J Med Chem. 1989 Feb;32(2):342-50.Cardiotonic agents. 9. Synthesis and biological evaluation of a series of (E)-4,5-dihydro-6-[2-[4-(1H-imidazol-1-yl)phenyl]ethenyl]-3 (2H)-pyridazinones: a novel class of compounds with positive inotropic, antithrombotic, and vasodilatory activities for the treatment of congestive heart failure. | ||||
| Ref 533015 | J Med Chem. 1989 Feb;32(2):342-50.Cardiotonic agents. 9. Synthesis and biological evaluation of a series of (E)-4,5-dihydro-6-[2-[4-(1H-imidazol-1-yl)phenyl]ethenyl]-3 (2H)-pyridazinones: a novel class of compounds with positive inotropic, antithrombotic, and vasodilatory activities for the treatment of congestive heart failure. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.